Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

Holista Colltech Limited (HCT.AX)

Compare
0.0320
0.0000
(0.00%)
At close: April 4 at 10:27:33 AM GMT+11
Loading Chart for HCT.AX
  • Previous Close 0.0320
  • Open 0.0320
  • Bid 0.0330 x --
  • Ask 0.0390 x --
  • Day's Range 0.0320 - 0.0320
  • 52 Week Range 0.0040 - 0.0350
  • Volume 280,098
  • Avg. Volume 188,349
  • Market Cap (intraday) 9.145M
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Food Ingredients, and Infection Control Solutions segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. The company also offers biogenic particles, low fat chips, and water soluble technology. Holista CollTech Limited is based in Subiaco, Australia.

www.holistaco.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HCT.AX

View More

Performance Overview: HCT.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

HCT.AX
146.15%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

HCT.AX
220.00%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

HCT.AX
13.51%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

HCT.AX
73.33%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: HCT.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HCT.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    9.14M

  • Enterprise Value

    10.69M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.60

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.91

  • Enterprise Value/EBITDA

    36.93

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.50%

  • Return on Assets (ttm)

    5.95%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.6M

  • Net Income Avi to Common (ttm)

    -84.21k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.72k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    53.31k

Research Analysis: HCT.AX

View More

Company Insights: HCT.AX

Research Reports: HCT.AX

View More

People Also Watch